Picture of Equillium logo

EQ — Equillium News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Equillium Inc reports results for the quarter ended in March - Earnings Summary

* Equillium Inc  EQ.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 27
cents per share.
    * Revenue was $8.88 million​; analysts expected $6.74
million. 
    * Equillium Inc's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had risen by
about 6.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Equillium Inc shares had fallen by 23.4% this quarter and
lost 47.2% so far this year.
    * The company reported a quarterly loss of $3.94 million.
    * Wall Street's median 12-month price target for Equillium
Inc is
$7.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 08:40 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.27          -0.11          Beat
 Dec. 31 2022      -0.03          0.08           Beat
 Sep. 30 2022      -0.38          -0.40          Missed
 Jun. 30 2022      -0.41          -0.41          Met

Recent news on Equillium

See all news